{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:30:39Z","timestamp":1774431039906,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the effects of iron (Fe) supplementation in maternal anemia on fetal fraction (FF) according to different gestational ages (GA) in pregnancies undergoing non-invasive prenatal testing (NIPT). FF is one of the key parameters that directly determines the analytical reliability of NIPT. Therefore, understanding the impact of hematologic and treatment-related variables on FF is important for optimal test timing and for minimizing false-negative results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective, single-center study included 308 pregnant women who underwent NIPT between January 2020 and December 2025. Cases with obesity, multiple pregnancies,\n                      <jats:italic>in vitro<\/jats:italic>\n                      fertilization conception, chronic systemic diseases, or medication use were excluded to obtain a homogeneous cohort. Hematologic parameters and FF values were evaluated according to GA and Fe supplementation status. Correlation, subgroup, and multivariable regression analyses were performed using non-parametric statistical methods.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median maternal age was 33.5\u202fyears, and the median GA was 14.43\u202fweeks. A moderate positive correlation was observed between GA and FF (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u202f=\u202f0.399,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), whereas Hb levels showed only a weak positive correlation with FF (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u202f=\u202f0.112,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.050). No significant associations were found between FF and hematocrit, white blood cell, or platelet counts. The median FF was significantly higher after 16\u202fweeks of gestation (11.7% vs. 8.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Notably, among pregnancies \u226516\u202fweeks, FF was significantly lower in women receiving Fe supplementation compared with those who did not (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.010), whereas no significant difference was observed before 16\u202fweeks. In multivariable regression analysis adjusting for GA, Hb level at the time of NIPT, and MA, only GA remained independently associated with FF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although crude analyses suggested lower FF values among women receiving Fe supplementation after 16\u202fweeks of gestation, multivariable regression analysis indicated that GA remained the primary determinant of FF. Therefore, the apparent association between Fe supplementation and FF likely reflects underlying GA-related and hematologic differences rather than a direct effect of Fe therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1772334","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:56:34Z","timestamp":1774421794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of iron treatment on fetal fraction according to gestational weeks in maternal anemia"],"prefix":"10.3389","volume":"13","author":[{"given":"Seniye Burcu","family":"Torumtay Alic","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, Hitit University Faculty of Medicine","place":["\u00c7orum, T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1088745","DOI":"10.3389\/fmed.2023.1088745","article-title":"White blood cell count affects fetal fraction and test failure rates in noninvasive prenatal screening","volume":"10","author":"Qiao","year":"2023","journal-title":"Front Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"812781","DOI":"10.3389\/fped.2022.812781","article-title":"Factors affecting the fetal fraction in noninvasive prenatal screening: a review","volume":"10","author":"Deng","year":"2022","journal-title":"Front Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41436-020-01009-5","article-title":"High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening","volume":"23","author":"Welker","year":"2021","journal-title":"Genet Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/pd.5620","article-title":"Fetal fraction and noninvasive prenatal testing: what clinicians need to know","volume":"40","author":"Hui","year":"2020","journal-title":"Prenat Diagn"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12967-019-1871-x","article-title":"An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study","volume":"17","author":"Hu","year":"2019","journal-title":"J Transl Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"417.e1","DOI":"10.1016\/j.ajog.2021.04.212","article-title":"Obesity and no-call results: optimal timing of cell-free DNA testing and redraw","volume":"225","author":"Hopkins","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ajog.2021.05.026","article-title":"Is there an optimal gestational age for cell-free DNA testing in maternal obesity?","volume":"225","author":"Zhen","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"875588","DOI":"10.3389\/fmed.2022.875588","article-title":"The effect of elevated alanine transaminase on non-invasive prenatal screening failures","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"811385","DOI":"10.3389\/fmed.2021.811385","article-title":"Lipid metabolism affects fetal fraction and screen failures in non-invasive prenatal testing","volume":"8","author":"Cao","year":"2021","journal-title":"Front Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pd.4804","article-title":"The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon","volume":"36","author":"Yaron","year":"2016","journal-title":"Prenat Diagn"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/03630269.2014.938163","article-title":"Thalassemias and hemoglobinopathies in Turkey","volume":"38","author":"Canatan","year":"2014","journal-title":"Hemoglobin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1373\/clinchem.2017.272401","article-title":"DNA of erythroid origin is present in human plasma and informs the types of anemia","volume":"63","author":"Lam","year":"2017","journal-title":"Clin Chem"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"E5503","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.18502\/jri.v24i4.14149","article-title":"Maternal and fetal factors affecting cell-free fetal DNA (cffDNA) fraction: a systematic review","volume":"24","author":"Zaki-Dizaji","year":"2023","journal-title":"J Reprod Infertil"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/pd.4625","article-title":"Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing","volume":"35","author":"Kinnings","year":"2015","journal-title":"Prenat Diagn"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/pd.4119","article-title":"Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma","volume":"33","author":"Wang","year":"2013","journal-title":"Prenat Diagn"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40246-019-0244-0","article-title":"Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening","volume":"13","author":"Hou","year":"2019","journal-title":"Hum Genomics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ijlh.13551","article-title":"Laboratory approach to investigation of anemia in pregnancy","volume":"43","author":"Agarwal","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12884-019-2619-6","article-title":"Plasma volume expansion across healthy pregnancy: a systematic review and meta-analysis of longitudinal studies","volume":"19","author":"Aguree","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1080\/14767058.2017.1330881","article-title":"Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy","volume":"31","author":"Scott","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.62347\/MTQT6463","article-title":"High platelet distribution width affects the detection of fetal fraction of cell-free DNA detected by non-invasive prenatal testing","volume":"17","author":"Zhang","year":"2025","journal-title":"Am J Transl Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"139851","DOI":"10.4061\/2011\/139851","article-title":"Erythroblast enucleation","volume":"2011","author":"Keerthivasan","year":"2011","journal-title":"Stem Cells Int"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1182\/blood-2008-03-077883","article-title":"Erythroblastic islands: niches for erythropoiesis","volume":"112","author":"Chasis","year":"2008","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1772334\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:56:35Z","timestamp":1774421795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1772334\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":25,"alternative-id":["10.3389\/fmed.2026.1772334"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1772334","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"article-number":"1772334"}}